Pharmanutra S.p.A. (FRA:761)
Germany flag Germany · Delayed Price · Currency is EUR
66.40
+1.00 (1.53%)
At close: Feb 20, 2026

Pharmanutra Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
628523542601730364
Market Cap Growth
26.19%-3.62%-9.76%-17.67%100.53%60.68%
Enterprise Value
627523552595710350
Last Close Price
66.4052.9154.1659.6970.12-
PE Ratio
36.0031.4742.2639.9453.0125.87
PS Ratio
4.944.505.397.2410.716.41
PB Ratio
9.518.409.9711.8016.199.65
P/TBV Ratio
15.0712.7916.3819.8718.3011.18
P/FCF Ratio
60.2532.16--47.3235.98
P/OCF Ratio
43.4725.5044.8534.4135.7630.85
EV/Sales Ratio
4.934.505.497.1610.416.17
EV/EBITDA Ratio
19.8117.2921.7224.5636.7623.19
EV/EBIT Ratio
22.2519.1124.0025.7838.7824.71
EV/FCF Ratio
60.1632.17--46.0034.61
Debt / Equity Ratio
0.320.390.520.350.140.04
Debt / EBITDA Ratio
0.660.791.100.730.330.11
Debt / FCF Ratio
2.011.49--0.410.16
Net Debt / Equity Ratio
-0.01-0.080.05-0.18-0.61-0.51
Net Debt / EBITDA Ratio
-0.03-0.160.11-0.38-1.43-1.27
Net Debt / FCF Ratio
-0.09-0.30-2.501.05-1.79-1.89
Asset Turnover
1.081.010.950.971.111.13
Inventory Turnover
6.817.537.7610.1315.1316.15
Quick Ratio
1.601.951.701.963.083.39
Current Ratio
2.192.382.122.283.323.63
Return on Equity (ROE)
27.73%28.39%24.36%31.34%33.26%42.73%
Return on Assets (ROA)
14.96%14.88%13.54%16.82%18.58%17.61%
Return on Invested Capital (ROIC)
25.90%29.08%25.63%50.00%74.25%82.60%
Return on Capital Employed (ROCE)
31.80%30.40%27.20%31.00%33.50%34.90%
Earnings Yield
2.78%3.18%2.37%2.50%1.89%3.87%
FCF Yield
1.66%3.11%-0.21%-1.45%2.11%2.78%
Dividend Yield
1.53%1.89%1.57%1.34%1.01%-
Payout Ratio
54.97%49.20%60.11%45.53%47.10%31.64%
Buyback Yield / Dilution
0.58%0.61%0.05%0.09%--
Total Shareholder Return
2.11%2.50%1.62%1.43%1.01%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.